UnitedHealth Group Incorporated (NYSE:UNH – Get Free Report)’s share price was up 9.3% during trading on Tuesday after Sanford C. Bernstein raised their price target on the stock from $405.00 to $411.00. Sanford C. Bernstein currently has an outperform rating on the stock. UnitedHealth Group traded as high as $312.43 and last traded at $307.55. Approximately 21,966,661 shares traded hands during mid-day trading, an increase of 123% from the average daily volume of 9,840,573 shares. The stock had previously closed at $281.36.
UNH has been the topic of several other reports. Evercore upgraded shares of UnitedHealth Group to a “strong-buy” rating in a research report on Tuesday, January 6th. Oppenheimer dropped their price target on shares of UnitedHealth Group from $415.00 to $385.00 and set an “outperform” rating on the stock in a research report on Wednesday, January 28th. Weiss Ratings cut shares of UnitedHealth Group from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, March 2nd. HSBC upgraded shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $300.00 price target on the stock in a research report on Tuesday. Finally, Royal Bank Of Canada dropped their price target on UnitedHealth Group from $408.00 to $361.00 and set an “outperform” rating on the stock in a research note on Wednesday, January 28th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating, eight have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $363.42.
Check Out Our Latest Stock Report on UnitedHealth Group
Trending Headlines about UnitedHealth Group
- Positive Sentiment: CMS finalized a materially larger?than?expected 2027 Medicare Advantage payment increase (net +2.48%), which adds >$13B to the MA program and directly supports UnitedHealth’s Medicare book and margins. Trump administration finalizes better-than-feared Medicare Advantage payment rate in boost to health insurers (CNBC)
- Positive Sentiment: Market reaction: UNH led a managed?care relief rally after the CMS news, with coverage noting the move erased much of the regulatory risk that had pressured the stock. UnitedHealth Rockets 11%… (247WallSt)
- Positive Sentiment: Analysts moved quickly: Bank of America and Sanford C. Bernstein among firms raising price targets and ratings, signaling investor confidence that the MA lift supports earnings and valuation recovery. UnitedHealth Price Target Raised to $337 by BofA (247WallSt) Sanford C. Bernstein raises UNH target (TickerReport)
- Positive Sentiment: Several deep?dive pieces argue the MA rate boost materially improves UNH’s margin outlook and could accelerate a repricing if cost?cutting and Optum initiatives continue to reduce medical?cost run?rate. UnitedHealth: The CMS Boost Changes Everything Now (Seeking Alpha) Quantifying The Impact Of The New CMS Payment Increase (Seeking Alpha)
- Neutral Sentiment: Some headlines attribute part of the policy shift to new CMS leadership (mention of Dr. Oz) — a possible governance/regulatory angle to monitor but not an immediate earnings driver. Why UnitedHealth Group Rallied Today (Motley Fool)
- Neutral Sentiment: Upcoming catalyst: UNH reports Q1 results on April 21 — the print and management commentary will be the next major test of whether the MA tailwind offsets lingering cost pressure. Is April 21 When UnitedHealth Group Finally Sheds Its Problem Past? (247WallSt)
- Negative Sentiment: Despite the MA boost, analysts and coverage warn persistent elevated medical costs and prior weak guidance remain risks — earnings recovery depends on sustaining margin improvement and execution from Optum cost initiatives. UnitedHealth Jumps on CMS’ MA Rate Boost: How to Position Now (Zacks)
Hedge Funds Weigh In On UnitedHealth Group
Several institutional investors and hedge funds have recently bought and sold shares of the business. Brighton Jones LLC lifted its holdings in shares of UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after buying an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC lifted its holdings in shares of UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after buying an additional 2,324 shares during the last quarter. CMT Capital Markets Trading GmbH acquired a new position in shares of UnitedHealth Group during the second quarter worth approximately $340,000. Flow Traders U.S. LLC bought a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $356,000. Finally, Jump Financial LLC bought a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $377,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.
UnitedHealth Group Stock Up 9.3%
The business has a 50-day simple moving average of $281.61 and a two-hundred day simple moving average of $319.24. The stock has a market capitalization of $279.16 billion, a P/E ratio of 23.32, a PEG ratio of 1.28 and a beta of 0.40. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.72.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 EPS for the quarter, topping the consensus estimate of $2.09 by $0.02. The company had revenue of $113.73 billion for the quarter, compared to analysts’ expectations of $113.38 billion. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The business’s revenue for the quarter was up 12.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $6.81 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.9%. The ex-dividend date was Monday, March 9th. UnitedHealth Group’s dividend payout ratio is presently 67.02%.
About UnitedHealth Group
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
Further Reading
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
